Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Bullboard Posts
Comment by 1hot-techwomanon Apr 20, 2018 9:26am
221 Views
Post# 27916330

RE:Look for Abcann to be bought out $$$$$

RE:Look for Abcann to be bought out $$$$$
srtman03 wrote: ABcann Global Stands Out with Its Cannabis Cultivation Technologies April 20, 2018 Share on Facebook Tweet on Twitter Share on Linkedin Save Article ABcann Global Corporation (TSXV:ABCN) estimates its revenues to grow multifold through 2021, reaching $500 million from less than $1.0 million run rate SmallCapPower | April 20, 2018: ABcann Global Corporation (TSXV:ABCN) is a junior cannabis player holding a niche in cultivation technologies that deliver higher yields and consistent quality. ABcann is planning aggressive expansion of its flagship facility in Napanee, Ontario, with production targets of over 30,000 kgs annually by 2019. For Our Complete Coverage Of Canadian Marijuana Stocks Click Here The correction in cannabis stocks over the past two months has had a devastating effect on junior cannabis players such as ABcann Global. From the high of $3.85 on January 25, 2018, the share price of ABcann has fallen 59% to its recent price of $1.59. As the Company continues its expansion activities over the next two years, increasing its production and revenues, its stock price could rebound. ABcann Global estimates its revenues to grow multifold through 2021, reaching $500 million from less than $1.0 million run rate, as of September 30, 2017. An important catalyst for the stock would be the completion of its 30,000 sq. ft Vanluven facility in Napanee by mid-2018, for an output of 1,400 kgs annually, that would target both the medical and adult-use markets.


Abcann is estimating to do $500 Million in revenue by 2021? WOW :) Back up the truck !!! GLTA
Bullboard Posts